期刊文献+

自动校正凝血酶曲线法监测脑出血患者凝血功能的初步研究 被引量:9

Application of calibrated automated thrombography in monitoring coagulation function in cerebral hemorrhage patients
下载PDF
导出
摘要 目的采用自动校正凝血酶曲线法监测患者脑出血后机体凝血功能的变化状态。方法收集经头颅CT确诊、发病18h内入院的自发性脑出血患者20例作为脑出血组,选择年龄、性别匹配的健康体检者29例作为对照组。对照组体检时、脑出血组于入院6h内采用流行病学调查方式进行调查,同时进行实验室检查;脑出血组于入院第4、8和15天或出院时,再次采用自动校正凝血酶曲线法检测机体凝血功能。结果脑出血组患者入院时、入院第4和8天的延迟时间高于对照组[(9.17±8.90)min、(7.72±5.55)min、(6.56±4.44)min vs(3.26±0.77)min,P=0.002];入院时、入院第4、8和15天或出院时凝血酶生成潜力、峰值低于对照组,达峰时间长于对照组(P<0.05)。结论脑出血患者在初期呈低凝状态,凝血功能于第15天或出院时基本恢复,但仍低于健康人群。 Objective To study the application of calibrated automated thrombography in monitoring coagulation function in cerebral hemorrhage (CH) patients.Methods Twenty spontaneious CH patients admitted to our hospital within 18 h after onset of their disease served as a CH group and 29 age-and gender-matched subjects undergoing physical examination served as a control group in this study.Patients in CH group underwent laboratory tests within 6 h after admission and their coagulation function was tested on days 4,8 and 15 after admission or at the time when they were discharged by calibrated automated thrombography.Results The delayed time of coagulation was longer (P=0.002) while the ETP and its peak value were lower and the time to reach its peak value was longer in CH group than in control group at admission and on days 4 and 8 after admission.Conclusion The early coagulation function is low in CH patients and returns to its normal level on day 15 after admission or at the time when they are discarged.However,it is still lower than that in healthy populations.
出处 《中华老年心脑血管病杂志》 CAS 2015年第1期70-72,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 凝血酶 凝血酶原时间 凝血酶时间 脑出血 thrombin prothrombin time thrombin time cerebral hemorrhage
  • 相关文献

参考文献1

二级参考文献18

  • 1Ay Y, Balkan C, Karapinar DY, et al.Feasibility of using thrombin generation assay (TGA) for monitoring of haemostasis during supplementation therapy in haemophilic patients without inhibitors.Haemophilia, 2012; 174, 154-67.
  • 2Ay Y, Balkan C, Karapinar DY, et al.Feasibility of Using Thrombin Generation Assay (TGA) for Monitoring Bypassing Agent Therapy in Patients With Hemophilia Having Inhibitors.Clin Appl Thromb Hemost, 2012; 156, 173-89.
  • 3Gatt A, van Veen JJ, Woolley AM, et al.Thrombin generation assays are superior to traditional tests in assessing anticoagu?lation reversal in vitro.Thromb Haemost, 2008; 100, 350-5.
  • 4Hacquard M, Perrin J, Lelievre N, et al.Inter-individual variability of effect of 7 low molecular weight antithrombin?dependent anticoagulants studied in vitro with calibrated automated thrombography.Thromb Res, 2011; 127, 29-34.
  • 5Gatt A, van Veen JJ, Bowyer A, et al.Wide variation in thrombin generation in patients with atrial fibrillation and therapeutic International Normalized Ratio is not due to inflammation.Br J Haematol, 2008; 142,946-52.
  • 6Ay C.and Pabinger I.Predictive potential of haemostatic biomarkers for venous thromboembolism in cancer patients.Thromb Res, 2012; 129 Suppll, 56-9.
  • 7Brummel-Ziedins K, Undas A, Orfeo T, et al.Thrombin generation in acute coronary syndrome and stable coronary artery disease: dependence on plasma factor composition.J Thromb Haemost, 2008; 6,104-10.
  • 8Hemker HC, Wielders 5, Kessels H, et al.Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential.Thromb Haemost, 1993; 70, 617-24.
  • 9Besser M, Baglin C, Luddington R, et al.High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study.J Thromb Haemost, 2008; 6, 1720-5.
  • 10Gerotziafas GT, Galea V, Mbemba E, et al.Effect of Low Molecular Weight Heparins and Fondaparinux upon Thrombin Generation Triggered by Human Pancreatic Cancer Cells BXPC3.Curr Vasc Pharmacol, 2012; 156, 1234-40.

共引文献1

同被引文献68

引证文献9

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部